phrama sector

Slide 1 Screening of Latent Tuberculosis before treatment with TNF  blockers Ori Elkayam M.D Tel Aviv Medical Center Slide 2 Guidelines of the Israeli association of Rheumatology…

Slide 1Concerns About Adverse Event Reporting in Randomized Clinical Trials Yusuf Yazıcı, MD NYU Hospital for Joint Diseases [email protected] Slide 2 Overview Completeness…

Slide 1 ©2013 MFMER | slide-1 Sarcoidosis therapy Rob Vassallo, MD Mayo Clinic, Rochester, MN. Pneumotrieste 2014 April 7-9, 2014. Slide 2 ©2013 MFMER | slide-2 Disclosures…

Slide 1 Case Report  39-year-old white male, diagnosed with Rf+ rheumatoid arthritis at the age of 17, presented to his primary care physician with shortness of breath…

Slide 1 INTERPATIENT VARIABILITY OF DRUG DISPOSITION & DOSAGE ADJUSTMENT Readings (Applied Biopharm & PK 5 th Ed.): Chp 12. Pharmacogenetics p 355-68. Chp 21. Renal…

Slide 1 HEPATITIS 2014 BC Slide 2 CHRONIC HEPATITIS B THE PROBLEM 350,000,000 PEOPLE HAVE IT IT IS TRANSMITTED MOTHER TO CHILD WHERE IT IS ENDEMIC IT CAN BE TRANSMITTED VIA…

Osteoporosis Modern Treatment of Disease: The importance of medication Adherence Current Events http://www.forbes.com/sites/wendydiller/2014/10/15/is-specialty-pharma-pricing-at-a-tipping-point/?ss=pharma-healthcare…

Biological Differentiation Part II Dubai, United Arab Emirates January 19th, 2009 Prof. Joachim R. Kalden Director emeritus Dept. of Internal Medicine III Div. of Molecular…

AUTOIMMUNE DISEASES DR IDA DZIFA KUWORNOO PHYSICIAN SPECIALIST KBTH Greek word âautoâ meaning self. Due to failure of an organism to recognize its own constituent parts…